Skip to main content

Oncology Startups

Updated July 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 300 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
300
Total Funding
$1.2B
Avg Funding
$46.7M
Global Reach
8
countries

Top Cities for Oncology

South San Francisco
Klosterneuburg
Baltimore
Waltham
Los Angeles
Closter

Recently Funded Companies

Export
South San Francisco, United States

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

$75.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Klosterneuburg, Austria

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

$7.3M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Baltimore, United States

Haystack Oncology enables precision oncology to optimize treatment strategies.

$56.0M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Waltham, United States

Mural Oncology is a protein engineering platform to reimagine cytokine-based immunotherapies for the treatment of cancer.

$275.0M raised
Nov 2023

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Preveta is a SaaS care navigation platform for specialty and oncology care.

$2.4M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Closter, United States

Chemo Mouthpiece is an medical device company that develops and commercializes propriety oral cryotherapy products for cancer patients.

$900K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Beltsville, United States

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

$21.5M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

$45.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Houston, United States

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

$7.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Villejuif, France

Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.

$1.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Culver City, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

$96.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Redwood City, United States

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

$25.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

$14.1M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

$58.9M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

$92.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Saint Laurent, Canada

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

$101.2M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Cambridge, United States

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

$155.3M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

San Carlos, United States

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

$2.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Rockville, United States

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

$50.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Halifax, Canada

Adaptiiv specializes in medical device and software development that helps practitioners in cancer treatment operations.

$963K raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Berkeley, United States

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

$25.5M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Treating the seeds of cancer

$4.7M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

$27.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Quebec, Canada

BioTwin Preventative Health and Decision Support Tools based on Human Virtual Twin derived from biometrics & biomarkers

$2.5M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Amsterdam, The Netherlands

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

$21.9M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Showing 276 to 300 of 300 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 300 oncology companies tracked in the VCBacked database.

Average Funding
$46.7M
Total Funding Tracked
$1.2B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.Cambridge
3 companies$218.9M
2.South San Francisco
1 companies$75.0M
3.Klosterneuburg
1 companies$7.3M
4.Baltimore
1 companies$56.0M
5.Waltham
1 companies$275.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked